Apellis Pharmaceuticals (APLS) PT Raised to $60 at Wedbush
Tweet
Share
E-mailGet Alerts APLS Hot Sheet
Price: $41.03 --0%
Rating Summary:
6 Buy, 23 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Rating Summary:
6 Buy, 23 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Join SI Premium – FREE
Wedbush analyst Laura Chico raised the price target on Apellis Pharmaceuticals (NASDAQ: APLS) to $60.00 (from $39.00) while maintaining a Neutral rating.
You May Also Be Interested In
- NRW Holdings Ltd. (NWH:AU) PT Raised to AUD8.47 at Canaccord
- Rubrik Inc (RBRK) PT Raised to $120 at Oppenheimer; Sees Another 'Beat and Raise'
- Marti Technologies (MRT) PT Lowered to $3.50 at Roth/MKM
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
